Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Khiron Life Sciences Corp.
  6. News
  7. Summary
    KHRN   CA49374L3065

KHIRON LIFE SCIENCES CORP.

(KHRN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Khiron Life Sciences Corp.: Invitation to the Benzinga Virtual Cannabis Capital Conference

06/01/2021 | 08:05am EDT

Detroit, Michigan--(Newsfile Corp. - June 1, 2021) - Khiron Life Sciences Corp. (TSXV: KHRN) will be presenting at the Benzinga Cannabis Capital Conference taking place on June 3-4, 2021. We invite our shareholder and all interested parties to join us for a full day of networking, dealmaking and discovery. Sign up to get a free spectator pass for the event: https://events.benzinga.com/ccc-free-registration

About Benzinga Cannabis Capital Conference

Benzinga's virtual Cannabis Capital Conference is guaranteed to offer participants all the benefits of an immersive and robust in-person conference from any remote location. The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis space. Don't miss this opportunity to connect with THE cannabis movers and shakers from across the globe.

For more information and/or to register for the conference please visit: https://events.benzinga.com/ccc-free-registration

We look forward to seeing you there.

For further information:

Khiron Life Sciences Corp.
Paola Ricardo
416-540-2970
pricardo@khiron.ca
https://investors.khiron.ca/corporate-information


© Newsfilecorp 2021
All news about KHIRON LIFE SCIENCES CORP.
07/29KHIRON LIFE SCIENCES : Welcomes Dr. Eduardo Faveret as Medical Director for Braz..
PR
07/26KHIRON LIFE SCIENCES : Up 8.8% as Colombia Expands Medical Marijuana Program and..
MT
07/08KHIRON LIFE SCIENCES : Closes C$12.35 Million Private Placement of Share Units
MT
07/08KHIRON LIFE SCIENCES : Closes $12.3 Million Equity Financing
AQ
07/06UPDATE : Khiron Drops Near 15% as Details Proposed Offering of Securities
MT
07/06KHIRON LIFE SCIENCES : Announces Terms of Overnight Marketed Offering
AQ
07/06KHIRON LIFE SCIENCES : Details Proposed Offering of Securities
MT
07/06Khiron Life to Seek Acquisitions
CI
07/05KHIRON LIFE SCIENCES : Announces Proposed Offering of Securities
AQ
07/02KHIRON LIFE SCIENCES : Announces Results of 2021 Annual General Meeting
PR
More news
Financials
Sales 2021 15,3 M 12,2 M 12,2 M
Net income 2021 -22,2 M -17,8 M -17,8 M
Net cash 2021 11,0 M 8,80 M 8,80 M
P/E ratio 2021 -1,55x
Yield 2021 -
Capitalization 55,5 M 44,5 M 44,4 M
EV / Sales 2021 2,91x
EV / Sales 2022 0,99x
Nbr of Employees -
Free-Float 94,7%
Chart KHIRON LIFE SCIENCES CORP.
Duration : Period :
Khiron Life Sciences Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KHIRON LIFE SCIENCES CORP.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,31 CAD
Average target price 0,95 CAD
Spread / Average Target 206%
EPS Revisions
Managers and Directors
Álvaro F. Torres Chief Executive Officer & Director
Joel Friedman Chief Financial Officer
Chris Naprawa Chairman
Jairo Espinoza Vice President-Medical Affairs
Manuel Buendia Vice President-Operations
Sector and Competitors